• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE MAVERICK²¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE MAVERICK²¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number H7493892809200
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Intimal Dissection (1333)
Date of Event 01/07/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Age at time of event: 18 years or older.Device evaluated by mfr.: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event or Problem Description
It was reported that vessel dissection occurred.The target lesion was located in the moderately tortuous and mildly calcified mid right coronary artery (rca).A 2.00mm x 9mm maverick²¿ balloon catheter was advanced to dilate the lesion but failed to cross.However, a vessel dissection was noticed in the rca.The physician then referred the patient for coronary artery bypass graft (cabg).No further patient complications were reported and the patient's status was stable.
 
Additional Manufacturer Narrative
Device evaluated by mfr: returned product consisted of a maverick 2 balloon catheter.The balloon was loosely folded with fluid in the balloon and lumen.The balloon, markerband, proximal weld, inner/outer shaft, and hypotube were microscopically inspected.Inspection revealed numerous kinks in the hypotube.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event or Problem Description
It was reported that vessel dissection occurred.The target lesion was located in the moderately tortuous and mildly calcified mid right coronary artery (rca).A 2.00mm x 9mm maverick²¿ balloon catheter was advanced to dilate the lesion but failed to cross.However, a vessel dissection was noticed in the rca.The physician then referred the patient for coronary artery bypass graft (cabg).No further patient complications were reported and the patient's status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAVERICK²¿
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
MDR Report Key6278677
Report Number2134265-2017-00248
Device Sequence Number1075635
Product Code LOX
UDI-Device Identifier08714729369875
UDI-Public(01)08714729369875(17)20171231(10)17566629
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
P860019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2017
Device Model NumberH7493892809200
Device Catalogue Number38928-0920
Device Lot Number17566629
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/30/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 01/07/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date01/26/2017
Supplement Report FDA Received Date03/09/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-